We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PBR:NYSEPetroleo Brasileiro S.A. Petrobras Analysis

Data as of 2026-08-10 - not real-time

$18.36

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Petróleo Brasileiro S.A. - Petrobras is priced at $18.36 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 12.7%. With RSI at 51.4 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $17.44 and resistance at $19.46.
Valuation screens as undervalued: a P/E of 4.6 sits below the sector average of 20.2. Analyst price targets sit 20.9% above the current price. The 9.52% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 31.6%, a beta of -0.10 and a maximum drawdown of 27.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.

Top Market Events

On June 19, Petróleo Brasileiro S.A. – Petrobras NYSE:PBR revealed that the company’s Board of Directors has...Petróleo Brasileiro S.A. – Petrobras NYSE:PBR is one of the best dividend stocks to invest in, according to Jim...On June 20, Petróleo Brasileiro S.A. – Petrobras NYSE:PBR ’s board approved a $1.2 billion investment to develop a...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 16.46
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 4.6 versus sector average of 20.2
  • Trading above the 200-day average of 16.46

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • P/E of 4.6 versus sector average of 20.2
  • Analyst targets imply +20.9% versus the current price
  • Profit margin of 21.6% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth0.40%
Profit Margin21.60%
P/E Ratio4.6
ROE25.60%
ROA8.23%
Debt/Equity83.27
P/B Ratio1.4
Op. Cash Flow$195.0B
Free Cash Flow$82.9B
Industry P/E20.2

Technical Analysis

TrendBullish
RSI51.4
Support$17.44
Resistance$19.46
MA 20$18.44
MA 50$17.75
MA 200$16.46
MACDBearish
VolumeStable
Fear & Greed Index94.18

Valuation

Fair Value$117.30
Target Price$22.19
Upside/Downside20.89%
GradeUndervalued
TypeValue
Dividend Yield9.52%

Risk Assessment

Beta-0.10
Volatility31.57%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.